SREBF1 and atherosclerosis: As an instance, Zhang Y demonstrated that Dingxin Recipe IV mitigated atherosclerosis by adjusting lipid metabolism via the LXR-α/SREBP1 pathway and manipulating the gut microbiota of ApoE−/− mice fed a high-fat diet (141).